No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AHCO240816P12500
- 2.70
- 0.000.00%
15min DelayTrading Jun 28 15:50 ET
0.00High0.00Low
0.00Open2.70Pre Close0 Volume9 Open Interest12.50Strike Price0.00Turnover66.52%IV7.89%PremiumAug 16, 2024Expiry Date1.86Intrinsic Value100Multiplier25DDays to Expiry0.84Extrinsic Value100Contract SizeAmericanOptions Type-0.7735Delta0.1638Gamma3.94Leverage Ratio-0.0100Theta-0.0055Rho-3.05Eff Leverage0.0086Vega
Intraday
- 5D
- Daily
No Data
News
AdaptHealth Poised for Growth: Strong Q2 Outlook and Strategic Leadership Underpin Buy Rating
AdaptHealth Corp. Announces Second Quarter 2024 Earnings Release Date and Conference Call
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services,
Should You Investigate AdaptHealth Corp. (NASDAQ:AHCO) At US$10.61?
While AdaptHealth Corp. (NASDAQ:AHCO) might not have the largest market cap around , it saw a decent share price growth of 15% on the NASDAQCM over the last few months. The recent rally in
Implied Volatility Surging for AdaptHealth (AHCO) Stock Options
AdaptHealth Corp. (NASDAQ:AHCO) Shares Could Be 41% Below Their Intrinsic Value Estimate
AdaptHealth Executive Transition and Board Chair Appointment
Comments
$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
6
Despite promising growth forecasts, the company's P/S ratio is lower than expected due to major risk factors. The market shows hesitation about the company, despite high growth forecasted.
AdaptHealth's sales haven't grown significantly despite reinvestment into growth, causing investor concern. Their inconsistent high-growth stock traits suggest better returns elsewhere. The stock drop implies uncertain investor sentiment regarding the firm's future.
Insiders' net selling over the past year clouds the positive signal of high insider ownership levels, calling for investor caution due to associated risks.
Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
24
Read more